Internal Medicine, Endocrinology, Diabetes, & Metabolism · Chandler, AZ
NPI
1447231147
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2971 W Elliot Rd, Suite 1
Chandler, AZ, 85224
Phone (480) 733-5483
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
1,703 services
Medicare patients, 2024
419
Average age 73
Drug cost, 2024
$3.8M
8,215 prescriptions
Company payments, 2025
$2,638
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Seema Ahluwalia was code 99214 (office e&m - established), 906 times for 369 patients. In total Seema Ahluwalia billed 1,703 services in 21 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 906 | 369 | $89.69 | $81K |
| 95251 Test - Miscellaneous | Office | 263 | 102 | $25.24 | $6,637 |
| 99443 Telephone Services | Office | 124 | 76 | $70.21 | $8,706 |
| 99204 Office E&M - New | Office | 109 | 109 | $120.15 | $13K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 48 | 17 | $36.77 | $1,765 |
| 99212 Office E&M - Established | Office | 48 | 34 | $38.85 | $1,865 |
| 95249 Test - Miscellaneous | Office | 35 | 32 | $47.92 | $1,677 |
| 99215 Office E&M - Established | Office | 33 | 30 | $136.42 | $4,502 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 25 | 16 | $48.05 | $1,201 |
| 76536 Ultrasound - Nonspecific | Office | 21 | 21 | $80.88 | $1,699 |
| 95250 Test - Miscellaneous | Office | 16 | 14 | $107.45 | $1,719 |
By year: 2022 $109K for 1,271 services; 2023 $124K for 1,628 services; 2024 $127K for 1,703 services.
Medicare prescription drug claims, 2024
In 2024, the drug Seema Ahluwalia prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,168 prescriptions and refills. In total Seema Ahluwalia wrote 8,215 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,168 | 3,243 | 372 | $13K |
| Metformin Hcl Generic | 437 | 1,237 | 159 | $4,110 |
| Jardiance Empagliflozin | 399 | 940 | 130 | $541K |
| Glimepiride Generic | 395 | 1,110 | 136 | $5,276 |
| Ozempic Semaglutide | 325 | 607 | 92 | $557K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 315 | 792 | 119 | $66K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 304 | 828 | 150 | $41K |
| Atorvastatin Calcium Generic | 245 | 706 | 89 | $2,071 |
| Trulicity Dulaglutide | 227 | 384 | 55 | $385K |
| Methimazole Generic | 180 | 497 | 53 | $2,227 |
| Mounjaro Tirzepatide | 180 | 268 | 43 | $291K |
| Farxiga Dapagliflozin Propanediol | 129 | 294 | 49 | $157K |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 127 | 329 | 46 | $73K |
| Synthroid Levothyroxine Sodium | 125 | 302 | 31 | $9,812 |
| Metformin Hcl Er Metformin Hcl | 110 | 276 | 36 | $1,199 |
Brand drugs: 4,200 claims; generic drugs: 3,234 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Seema Ahluwalia $2,638 ($2,638 in general payments such as food, travel and fees) from 30 companies. The largest payer was Beta Bionics, Inc. with $709.
| Company | Payments | Amount |
|---|---|---|
| Beta Bionics, Inc. BBNX | 46 | $709 |
| Averitas Pharma Inc. | 4 | $193 |
| Medtronic, Inc. MDT | 11 | $178 |
| Radius Health, Inc. | 6 | $160 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $114 |
| Amneal Pharmaceuticals LLC AMRX | 6 | $108 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $105 |
| Amgen Inc. AMGN | 4 | $92.16 |
| Recordati_rare_diseases_inc. | 4 | $89.43 |
| Xeris Pharmaceuticals, Inc. | 4 | $87.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.